New Horizons In The Treatment Of Metastatic Castrate Resistant Prostate Cancer
“The nature of the body is the beginning of medical science”-Hippocrates. From the chosen Dhanvantri of ancient India to Imhotep of Egypt, to Huangdi of China, the disease was seen as a combination of the supernatural and the natural and medicine focused on healing the soul and the body. While prac...
Saved in:
Main Author: | Zein El Amir |
---|---|
Format: | Article |
Language: | English |
Published: |
Rawalpindi Medical University
2023-06-01
|
Series: | Journal of Rawalpindi Medical College |
Online Access: | https://www.journalrmc.com/index.php/JRMC/article/view/2330 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HTA and Reimbursement Status of Metastatic Hormone‑Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, and Metastatic Castration-Resistant Prostate Cancer Treatments in Europe: A Patient Access Landscape Review
by: Goran Bencina, et al.
Published: (2023-06-01) -
Cost-effectiveness Analysis of Radium-223 Dichloride in Metastatic Castration-Resistant Prostate Cancer Patients Without Previous Chemotherapy Treatment in Spain
by: Eva Tirado Mercier, et al.
Published: (2018-01-01) -
Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel
by: Keith L. Davis, et al.
Published: (2015-01-01) -
Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings
by: Armen Aprikian, et al.
Published: (2025-02-01) -
Identification of mitochondrial carrier homolog 2 as an important therapeutic target of castration-resistant prostate cancer
by: Yankui Liu, et al.
Published: (2025-02-01)